Source:http://linkedlifedata.com/resource/pubmed/id/19740343
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1 Suppl
|
pubmed:dateCreated |
2009-9-10
|
pubmed:abstractText |
Interleukin-27 (IL-27) is a new IL-12-related heterodimeric cytokine comprising a novel p28 molecule and the Epstein-Barr-virus-induced gene 3 (EBI3) molecules. It augments initiation of T helper type 1-mediated immunity by enhancing the proliferation and cytokine production of T cells. In this study, we examined whether a secreted form of IL-27 subunits would inhibit IL-27-mediated immunological responses. COS-7 cells transduced with the mouse (m) p28 gene secreted a monomeric mp28 protein; however, those transduced with the mEBI3 gene did not detect a mEBI3 protein in the culture supernatants. The secreted mp28 prevented the IL-27-mediated signal transduction and activator of transcription 1 phosphorylation and subsequently inhibited the IL-27-mediated intercellular adhesion molecule-1 induction and interferon-gamma production in CD4(+) T cells. We generated mp28-expressing murine carcinoma Colon 26 cells and inoculated a mixture of the mp28- and mIL-27-expressing Colon 26 cells into syngeneic BALB/c mice. Simultaneous production of mp28 and mIL-27 from Colon 26 cells suppressed IL-27-mediated anti-tumour effects in the mice. We examined the p28-mediated immune suppression by inoculating mp28-expressing myoblasts into allogeneic mice. Forced production of mp28 suppressed the allogeneic cytotoxic T-lymphocyte induction and subsequently retarded the graft rejection. Furthermore, production of both mp28 and mp40, which inhibits the functions of IL-12 and IL-23, prolonged the graft survival longer than the grafts expressing either mp28 or mp40. We propose that p28 can be a regulatory subunit for IL-27-mediated cellular immune responses and a possible therapeutic agent to suppress unfavourable immune responses.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cell Adhesion Molecules,
http://linkedlifedata.com/resource/pubmed/chemical/Ebi3 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-17,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Subunits,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cytokine,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin-12,
http://linkedlifedata.com/resource/pubmed/chemical/STAT1 Transcription Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Stat1 protein, mouse
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1365-2567
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
128
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
e816-25
|
pubmed:dateRevised |
2010-9-2
|
pubmed:meshHeading |
pubmed-meshheading:19740343-Animals,
pubmed-meshheading:19740343-CD4-Positive T-Lymphocytes,
pubmed-meshheading:19740343-COS Cells,
pubmed-meshheading:19740343-Cell Adhesion Molecules,
pubmed-meshheading:19740343-Cell Line, Tumor,
pubmed-meshheading:19740343-Cercopithecus aethiops,
pubmed-meshheading:19740343-Female,
pubmed-meshheading:19740343-Graft Survival,
pubmed-meshheading:19740343-Interferon-gamma,
pubmed-meshheading:19740343-Interleukin-17,
pubmed-meshheading:19740343-Mice,
pubmed-meshheading:19740343-Mice, Inbred BALB C,
pubmed-meshheading:19740343-Mice, Inbred C57BL,
pubmed-meshheading:19740343-Myoblasts,
pubmed-meshheading:19740343-Neoplasms,
pubmed-meshheading:19740343-Phosphorylation,
pubmed-meshheading:19740343-Protein Subunits,
pubmed-meshheading:19740343-Receptors, Cytokine,
pubmed-meshheading:19740343-Receptors, Interleukin-12,
pubmed-meshheading:19740343-STAT1 Transcription Factor,
pubmed-meshheading:19740343-T-Lymphocytes, Cytotoxic,
pubmed-meshheading:19740343-Th1 Cells,
pubmed-meshheading:19740343-Transduction, Genetic
|
pubmed:year |
2009
|
pubmed:articleTitle |
The secreted form of p28 subunit of interleukin (IL)-27 inhibits biological functions of IL-27 and suppresses anti-allogeneic immune responses.
|
pubmed:affiliation |
Division of Pathology, Chiba Cancer Centre Research Institute, Nitona, Chiba, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|